{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:27:09Z","timestamp":1792682829410,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ygyno.2008.07.018","type":"journal-article","created":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T08:42:51Z","timestamp":1219394571000},"page":"226-232","source":"Crossref","is-referenced-by-count":67,"title":["Risk factors for a serous cancer precursor (\u201cp53 signature\u201d) in women with inherited BRCA mutations"],"prefix":"10.1016","volume":"111","author":[{"given":"Aasia","family":"Saleemuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann K.","family":"Folkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.07.018_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2005.06.052","article-title":"Age-specific ovarian cancer incidence rate patterns in the United States","volume":"99","author":"Quirk","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib2","series-title":"WHO world cancer report","year":"2003"},{"key":"10.1016\/j.ygyno.2008.07.018_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5","article-title":"Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases","volume":"64","author":"Dalrymple","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.07.018_bib4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib5","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.018_bib6","first-page":"467","article-title":"Current issues in the pathology of ovarian cancer","volume":"50","author":"Rabban","year":"2005","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.07.018_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib8","first-page":"20","article-title":"Prevention of ovarian cancer: intraepithelial neoplasia","volume":"9","author":"Brewer","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.07.018_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"27","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2008.07.018_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.07.018_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","article-title":"Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes","volume":"89","author":"Barakat","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.07.018_bib13","series-title":"Diagnostic gynecologic and obstetric pathology","first-page":"793","article-title":"Pathogenesis of ovarian cancer","author":"Drapkin","year":"2006"},{"key":"10.1016\/j.ygyno.2008.07.018_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2008.07.018_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Gorgoulis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2008.07.018_bib19","first-page":"71","article-title":"Cellular UV damage responses\u2014functions of tumor suppressor p53","volume":"1755","author":"Latonen","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ygyno.2008.07.018_bib20","first-page":"107","article-title":"Aberrant crypt foci","volume":"26","author":"Alrawi","year":"2006","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.ygyno.2008.07.018_bib21","first-page":"1791","article-title":"Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin","volume":"150","author":"Ren","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib23","unstructured":"Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol (in press)."},{"key":"10.1016\/j.ygyno.2008.07.018_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.ygyno.2008.07.018_bib25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib26","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjc.6602239","article-title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","volume":"91","author":"Whittemore","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2008.07.018_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.018_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.07.018_bib30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/00016340701771034","article-title":"Updating on primary fallopian tube carcinoma","volume":"86","author":"Riska","year":"2007","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2008.07.018_bib31","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.07.018_bib32","unstructured":"Carlson JW, Miron A, Jarboe EA, Parast M, Hirsch MS, Lee Y, et al. Serous Tubal Intraepithelial Carcinoma (STIC): Its Potential Role in Primary Peritoneal Serous Carcinoma (PPSC) and Serous Cancer Prevention. J Clin Oncol, in press."},{"key":"10.1016\/j.ygyno.2008.07.018_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2008.07.018_bib34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2008.07.018_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement of risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.07.018_bib36","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer","volume":"60","author":"Whittemore","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2008.07.018_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/153537020422900613","article-title":"Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention","volume":"229","author":"Murdoch","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ygyno.2008.07.018_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","article-title":"Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer","volume":"89","author":"Schildkraut","year":"1997","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.ygyno.2008.07.018_bib39","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/jnci\/90.22.1729","article-title":"Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer","volume":"90","author":"Webb","year":"1998","journal-title":"J. Natl. Cancer. Inst."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T14:33:04Z","timestamp":1557757984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808005337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0090825808005337"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.07.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}